Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first 100 patients have been treated with the MitraClip® system in Europe.
Evalve
Trial Shows Important Clinical Benefit Of MitraClip® Therapy In High Risk Patients
Percutaneous mitral valve repair using the MitraClip® system in high-risk surgical patients with improves patient clinical status according to data from the registry arm of the EVEREST II study.
First Swiss Patients Treated With The Percutaneous MitraClip® System
Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced that the first series of patients have been successfully treated with the MitraClip® system at the Cardiocentro Ticino in Lugano, Switzerland.